Organon
OGN • NYSE
Organon is a drug manufacturers - general company in the healthcare sector trading on NYSE, led by CEO Joseph T. Morrissey Jr., with a market cap of $2.3B.
Market Cap$2.3B
Employees10.0K
CEOJoseph T. Morrissey Jr.
CountryUnited States of America
Healthcare
Drug Manufacturers - General
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Organon FAQ
Common questions about Organon
Organon is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open. Analysts estimate revenue of $1.5B.
Organon has approximately 10,000 employees.